Showing results (281-290 of 320) with videos related to
Sort By:
Pageof 32
Hypertension (Dallas, Tex. : 1979)|April 27, 2016
Persistent Increase in Blood Pressure After Renal Nerve Stimulation in Accessory Renal Arteries After Sympathetic Renal DenervationMark R de Jong, Annemiek F Hoogerwaard, Pim Gal, et al.Ebiomedicine|February 26, 2022
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patientsVirginie Montiel, Irina Lobysheva, Ludovic Gérard, et al.Cardiovascular Research|March 20, 2026
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in HypertensionMarek Rajzer, Wiktoria Wojciechowska, Andrzej Januszewicz, et al.Blood Pressure|May 11, 2017
Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertensionLotte Jacobs, Alexandre Persu, Qi-Fang Huang, et al.Plos Genetics|May 3, 2011
Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndromeMargot E Bowen, Eric D Boyden, Ingrid A Holm, et al.JAMA Cardiology|November 9, 2022
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical TrialMichel Azizi, Felix Mahfoud, Michael A Weber, et al.Plos One|November 1, 2011
Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignanciesFrancois P Duhoux, Geneviève Ameye, Virginie Lambot, et al.Nature Genetics|November 8, 2011
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeTwinkal C Pansuriya, Ronald van Eijk, Pio d'Adamo, et al.ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.Journal of Hypertension|February 4, 2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)Pantelis A Sarafidis, Alexandre Persu, Rajiv Agarwal, et al.Pageof 32